Clinical Trials Directory

Trials / Sponsors / Hua Medicine Limited

Hua Medicine Limited

Industry · 16 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
CompletedEvaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type II
Phase 12024-04-25
RecruitingA Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
Type2diabetes
Phase 42023-12-20
CompletedA Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
Type 2 Diabetes Mellitus
Phase 12019-04-23
CompletedDrug Interaction Study Between Dorzagliatin and Empagliflozin
Patients
Phase 12019-04-18
CompletedA Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
Type 2 Diabetes Mellitus
Phase 12019-02-18
CompletedDrug Interaction Study Between Dorzagliatin and Sitagliptin
Patients
Phase 12019-01-31
CompletedDDI Study Between Dorzagliatin and Rifampicin
Drug Interaction
Phase 12018-03-27
CompletedLong-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
Diabetes Mellitus, Type 2
Phase 32017-10-15
CompletedDDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin
Drug Interaction
Phase 12017-10-13
CompletedLong-term Efficacy and Safety of HMS5552 in T2DM Subjects
Diabetes Mellitus, Type 2
Phase 32017-07-18
CompletedHuman Mass Balance Study of HMS5552 in Healthy Subjects
Healthy Subject
Phase 12017-03-29
CompletedDrug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
Type 2 Diabetes Mellitus
Phase 12015-10-01
CompletedA Multi-center 12-week Study of HMS5552 in T2DM
Diabetes Mellitus, Type 2
Phase 22015-09-01
CompletedBeta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
Type 2 Diabetes
Phase 12015-03-01
CompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 12014-03-01
CompletedA Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers
Type II Diabetes Mellitus
Phase 12013-09-01